Prostate Cancer UK is urging the government to update NHS guidelines so that GPs can proactively start having conversations ...

Prostate cancer waiting times could be radically cut by an 'extremely encouraging' 20 minute test, scientists have revealed.

After skin cancer, prostate cancer is the most common cancer in men in the US. A new treatment is giving men more options.

Prostate Cancer UK says ministers have a 'moral imperative' to change the rules so GPs can proactively speak to at risk ...

Vir Biotechnology's recent share price rally is driven by their promising cancer program. Having shot to over a $1.5B market ...

A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...

Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double ...

Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...

Award follows extensive pre-clinical, single agent activity data generated by Prof. Colleen Nelson's lab at QUT in 'Aggressive Variant' prostate ca ...

British singer-songwriter and actor Omar Lye-Fook has revealed to The Voice, he was diagnosed with prostate cancer in 2023 ...

Vir Biotechnology posts encouraging initial data from phase I studies evaluating VIR-5818 and VIR-5500 in heavily pretreated patients with various solid tumors.